FOMX
Morgan Stanley’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,407,948
| Closed | -$4.69M | – | 6878 |
|
|
2019
Q4 | $4.69M | Buy |
1,407,948
+1,406,396
| +90,618% | +$4.68M | ﹤0.01% | 3267 |
|
|
2019
Q3 | $5K | Hold |
1,552
| – | – | ﹤0.01% | 6381 |
|
|
2019
Q2 | $4K | Sell |
1,552
-43,692
| -97% | -$113K | ﹤0.01% | 6381 |
|
|
2019
Q1 | $169K | Buy |
45,244
+17,037
| +60% | +$63.6K | ﹤0.01% | 5149 |
|
|
2018
Q4 | $101K | Buy |
28,207
+23,207
| +464% | +$83.1K | ﹤0.01% | 5558 |
|
|
2018
Q3 | $29K | Sell |
5,000
-49,580
| -91% | -$288K | ﹤0.01% | 6035 |
|
|
2018
Q2 | $274K | Buy |
54,580
+26,203
| +92% | +$132K | ﹤0.01% | 5412 |
|
|
2018
Q1 | $145K | Buy |
+28,377
| New | +$145K | ﹤0.01% | 5599 |
|
|
2017
Q3 | – | Sell |
-20
| Closed | – | – | 6674 |
|
|
2017
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 6704 |
|
|
2017
Q1 | $0 | Buy |
+20
| New | – | ﹤0.01% | 6658 |
|
|
2016
Q4 | – | Sell |
-832
| Closed | -$8K | – | 6607 |
|
|
2016
Q3 | $8K | Sell |
832
-14,565
| -95% | -$140K | ﹤0.01% | 6162 |
|
|
2016
Q2 | $98K | Buy |
15,397
+8,147
| +112% | +$51.9K | ﹤0.01% | 5253 |
|
|
2016
Q1 | $47K | Sell |
7,250
-14,606
| -67% | -$94.7K | ﹤0.01% | 5635 |
|
|
2015
Q4 | $177K | Sell |
21,856
-375
| -2% | -$3.04K | ﹤0.01% | 5150 |
|
|
2015
Q3 | $163K | Buy |
22,231
+3,069
| +16% | +$22.5K | ﹤0.01% | 5189 |
|
|
2015
Q2 | $196K | Buy |
19,162
+4,243
| +28% | +$43.4K | ﹤0.01% | 5249 |
|
|
2015
Q1 | $139K | Sell |
14,919
-920
| -6% | -$8.57K | ﹤0.01% | 5391 |
|
|
2014
Q4 | $111K | Buy |
15,839
+15,403
| +3,533% | +$108K | ﹤0.01% | 5505 |
|
|
2014
Q3 | $2K | Buy |
+436
| New | +$2K | ﹤0.01% | 6458 |
|